Five cases of BRAF V600E-mutant lung adenocarcinoma with high expression of programmed death ligand 1

RECOMMENDED

Lung Cancer

The Value of ¹⁸F-FDG PET/CT in Predicting the Response to PD-1 Blocking Immunotherapy in Advanced NSCLC Patients with High-Level PD-L1 Expression

★ 1 Recommended by Dr Martin Frey, Faculty Member

★ 1 Recommended by Dr Marcus Hesse, Faculty Member

Clin Lung Cancer

Vekens K, Everaert H, Neyns B, Ilsen B, Decoster L

doi: 10.1016/j.cllc.2021.03.001

COMMENTED

Epigenetic prediction of response to anti-PD-1 treatment in non-small-cell lung cancer: a multicentre, retrospective analysis

Lancet Respir Med.

Duruisseaux M, Martínez-Cardús A, Calleja-Cervantes ME, Moran S, Castro de Moura M, Davalos V, Piñeyro D, Sanchez-Cespedes M, Girard N, Brevet M, Giroux-Leprieur E, Dumenil C, Pradotto M, Bironzo P, Capelletto E, Novello S, Cortot A, Copin MC, Karachaliou N, Gonzalez-Cao M, Peralta S, Montuenga LM, Gil-Bazo I, Baraibar I, Lozano MD, Varela M, Ruffinelli JC, Palmero R, Nadal E, Moran T, Perez L, Ramos I, Xiao Q, Fernandez AF, Fraga MF, Gut M, Gut I, Teixidó C, Vilariño N, Prat A, Reguart N, Benito A, Garrido P, Barragan I, Emile JF, Rosell R, Brambilla E, Esteller M

doi: 10.1016/S2213-

RECOMMENDED

Lung Cancer

Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer

★ 3 Recommended by Alexander Meisel, Faculty Member

★ 2 Recommended by Dr Martin Frey, Faculty Member

★ 2 Recommended by Dr Marcus Hesse, Faculty Member

★ 2 Recommended by Dr Wolf-Dieter Janthur, Faculty Member

N Engl J Med.

Hellmann MD, Paz-Ares L, Bernabe Caro R, Zurawski B, Kim SW, Carcereny Costa E, Park K, Alexandru A, Lupinacci L, de la Mora Jimenez E, Sakai H, Albert I, Vergnenegre A, Peters S, Syrigos K, Barlesi F, Reck M, Borghaei H, Brahmer JR, O'Byrne KJ, Geese WJ, Bhagavatheeswaran P, Rabindran SK, Kasinathan RS, Nathan FE, Ramalingam SS

doi: 10.1056/NEJMoa1910231.

Ketamine induces apoptosis in lung adenocarcinoma cells by regulating the expression of CD69

Cancer Med.

Zhou X, Zhang P, Luo W, Zhang L, Hu R, Sun Y, Jiang H

doi: 10.1002/cam4.1288.

RECOMMENDED

Lung Cancer

Prognostic and predictive value of PD-L1 expression and tumour infiltrating lymphocytes (TiLs) in locally advanced NSCLC treated with simultaneous radiochemotherapy in the randomized, multicenter, phase III German Intergroup lung Trial (GILT)

★ 1 Recommended by Dr Martin Frey, Faculty Member

Lung Cancer

Tufman A, Neumann J, Manapov F, Sellmer L, Jung A, Kauffmann-Guerrero D, Kahnert K, Mertsch P, Borgmeier A, Semrau S, Rittmeyer A, Ulm B, Ulm K, Flentje M, Fietkau R, Huber RM

doi: 10.1016/j.lungcan.2021.07.008

RECOMMENDED

Lung Cancer

Steroid Use Independently Predicts for Poor Outcomes in Patients With Advanced NSCLC and High PD-L1 Expression Receiving First-Line Pembrolizumab Monotherapy

★ 2 Recommended by Dr Martin Frey, Faculty Member

★ 1 Recommended by Dr Marcus Hesse, Faculty Member

Clin Lung Cancer

Mountzios G, de Toma A, Economopoulou P, Friedlaender A, Banini M, Lo Russo G, Baxevanos P, Roila F, Banna GL, Christopoulou A, Jimenez B, Collazo-Lorduy A, Linardou H, Calles A, Galetta D, Addeo A, Camerini A, Pizzutilo P, Kosmidis P, Garassino MC, Proto C, Signorelli D, Metro G

doi: 10.1016/j.cllc.2020.09.017

RECOMMENDED

Further Publications

Donation after circulatory death in lung transplantation-five-year follow-up from ISHLT Registry

★ 1 Recommended by Dr Martin Frey, Faculty Member

J Heart Lung Transplant.

Van Raemdonck D, Keshavjee S, Levvey B, Cherikh WS, Snell G, Erasmus M, Simon A, Glanville AR, Clark S, D'Ovidio F, Catarino P, McCurry K, Hertz MI, Venkateswaran R, Hopkins P, Inci I, Walia R, Kreisel D, Mascaro J, Dilling DF, Camp P, Mason D, Musk M, Burch M, Fisher A, Yusen RD, Stehlik J, Cypel M, International Society for Heart and Lung Transplantation.

doi: 10.1016/j.healun.2019.09.007.

RECOMMENDED

Lung Cancer

Real-World Prevalence of PD-L1 Expression Among Tumor Samples From Patients With Non-Small-Cell Lung Cancer

★ 1 Recommended by Dr Martin Frey, Faculty Member

★ 1 Recommended by Dr Marcus Hesse, Faculty Member

Clin Lung Cancer.

Gelatti ACZ, Cordeiro de Lima VC, Freitas H, Werutsky G, Gaiger AM, Klock C, Viola PP, Shiang C, de Macedo MP, Lopes LF, De Marchi P, Albino da Silva EC, Moura F, Borges G, Zaffaroni F, Nunes Filho PR, Araujo LH, Mascarenhas E, Mathias C, Barrios C, Zukin M

doi: 10.1016/j.cllc.2020.04.007.

RECOMMENDED

Lung Cancer

Prognostic impact of KRAS mutation status for patients with stage IV adenocarcinoma of the lung treated with first-line pembrolizumab monotherapy

★ 2 Recommended by Dr Martin Frey, Faculty Member

Lung Cancer

Noordhof AL, Damhuis RAM, Hendriks LEL, de Langen AJ, Timens W, Venmans BJW, van Geffen WH

doi: 10.1016/j.lungcan.2021.04.001

Related content

The Value of 18F-FDG PET/CT in Predicting the Response to PD-1 Blocking Immunotherapy in Advanced NSCLC Patients with High-Level PD-L1 Expression

Epigenetic prediction of response to anti-PD-1 treatment in non-small-cell lung cancer: a multicentre, retrospective analysis

Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer

Ketamine induces apoptosis in lung adenocarcinoma cells by regulating the expression of CD69

Prognostic and predictive value of PD-L1 expression and tumour infiltrating lymphocytes (TiLs) in locally advanced NSCLC treated with simultaneous radiochemotherapy in the randomized, multicenter, phase III German Intergroup lung Trial (GILT)

Steroid Use Independently Predicts for Poor Outcomes in Patients With Advanced NSCLC and High PD-L1 Expression Receiving First-Line Pembrolizumab Monotherapy

Donation after circulatory death in lung transplantation-five-year follow-up from ISHLT Registry

Real-World Prevalence of PD-L1 Expression Among Tumor Samples From Patients With Non-Small-Cell Lung Cancer

Prognostic impact of KRAS mutation status for patients with stage IV adenocarcinoma of the lung treated with first-line pembrolizumab monotherapy

The Value of ¹⁸F-FDG PET/CT in Predicting the Response to PD-1 Blocking Immunotherapy in Advanced NSCLC Patients with High-Level PD-L1 Expression